Literature DB >> 22677069

Using single protein biomarkers to predict health and disease in diverse patient populations: a new role for assessment of immunoglobulin free light chains.

Mark T Drayson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22677069      PMCID： PMC3498045          DOI： 10.1016/j.mayocp.2012.04.004

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  14 in total

1.  Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

Authors:  A R Bradwell; H D Carr-Smith; G P Mead; L X Tang; P J Showell; M T Drayson; R Drew
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

2.  Lymphocyte sub-population cell counts are associated with the metabolic syndrome and its components in the Vietnam Experience Study.

Authors:  Anna C Phillips; Douglas Carroll; Catharine R Gale; Mark Drayson; G Neil Thomas; G David Batty
Journal:  Atherosclerosis       Date:  2010-08-19       Impact factor: 5.162

3.  A Case of Multiple Myeloma (Myelomatosis) with Bence-Jones Proteid in the Urine (Myelopathic Albumosuria of Bradshaw, Kahler's Disease),and a Summary of Published Cases of Bence-Jones Albumosuria: With a Report on the Chemical Pathology.

Authors:  F P Weber; R Hutchison; J J Macleod
Journal:  Med Chir Trans       Date:  1903

4.  Immunoglobulin aggregation leading to Russell body formation is prevented by the antibody light chain.

Authors:  Daniel Corcos; Michael J Osborn; Louise S Matheson; Fatima Santos; Xiangang Zou; Jennifer A Smith; Geoff Morgan; Amanda Hutchings; Maureen Hamon; David Oxley; Marianne Brüggemann
Journal:  Blood       Date:  2009-10-12       Impact factor: 22.113

Review 5.  Bence-Jones proteins and light chains of immunoglobulins (first of two parts).

Authors:  A Solomon
Journal:  N Engl J Med       Date:  1976-01-01       Impact factor: 91.245

6.  Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.

Authors:  Meletios Dimopoulos; Robert Kyle; Jean-Paul Fermand; S Vincent Rajkumar; Jesus San Miguel; Asher Chanan-Khan; Heinz Ludwig; Douglas Joshua; Jayesh Mehta; Morie Gertz; Hervé Avet-Loiseau; Meral Beksaç; Kenneth C Anderson; Philippe Moreau; Seema Singhal; Hartmut Goldschmidt; Mario Boccadoro; Shaji Kumar; Sergio Giralt; Nikhil C Munshi; Sundar Jagannath
Journal:  Blood       Date:  2011-02-03       Impact factor: 22.113

7.  Polyclonal immunoglobulin free light chain levels predict survival in myeloid neoplasms.

Authors:  Animesh Pardanani; Terra L Lasho; Christy M Finke; S Vincent Rajkumar; Preet Paul Singh; Rhett P Ketterling; Curtis A Hanson; Jerry A Katzmann; Ayalew Tefferi
Journal:  J Clin Oncol       Date:  2012-02-13       Impact factor: 44.544

8.  Serum test for assessment of patients with Bence Jones myeloma.

Authors:  Arthur R Bradwell; Hugh D Carr-Smith; Graham P Mead; Timothy C Harvey; Mark T Drayson
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

9.  Use of nonclonal serum immunoglobulin free light chains to predict overall survival in the general population.

Authors:  Angela Dispenzieri; Jerry A Katzmann; Robert A Kyle; Dirk R Larson; Terry M Therneau; Colin L Colby; Raynell J Clark; Graham P Mead; Shaji Kumar; L Joseph Melton; S Vincent Rajkumar
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

10.  INDIVIDUAL ANTIGENIC SPECIFICITY OF MYELOMA PROTEINS. CHARACTERISTICS AND LOCALIZATION TO SUBUNITS.

Authors:  H M GREY; M MANNIK; H G KUNKEL
Journal:  J Exp Med       Date:  1965-04-01       Impact factor: 14.307
View more
  2 in total

1.  Polyclonal immunoglobulin free light chain and chronic inflammation.

Authors:  Frank A Redegeld; Marco Thio; Tom Groot Kormelink
Journal:  Mayo Clin Proc       Date:  2012-10       Impact factor: 7.616

Review 2.  AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.

Authors:  E Jensen-Jarolim; H J Bax; R Bianchini; S Crescioli; T R Daniels-Wells; D Dombrowicz; E Fiebiger; H J Gould; S Irshad; J Janda; D H Josephs; F Levi-Schaffer; L O'Mahony; G Pellizzari; M L Penichet; F Redegeld; F Roth-Walter; J Singer; E Untersmayr; L Vangelista; S N Karagiannis
Journal:  Allergy       Date:  2017-10-05       Impact factor: 13.146
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.